These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 27816968)

  • 1. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
    Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
    Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
    Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
    Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer.
    Du Q; Li E; Liu Y; Xie W; Huang C; Song J; Zhang W; Zheng Y; Wang H; Wang Q
    Cancer Med; 2018 Feb; 7(2):325-335. PubMed ID: 29356357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.
    Blanco-Prieto S; Barcia-Castro L; Páez de la Cadena M; Rodríguez-Berrocal FJ; Vázquez-Iglesias L; Botana-Rial MI; Fernández-Villar A; De Chiara L
    BMC Cancer; 2017 Dec; 17(1):823. PubMed ID: 29207990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary N1, N12-diacetylspermine is a non-invasive marker for the diagnosis and prognosis of non-small-cell lung cancer.
    Takahashi Y; Sakaguchi K; Horio H; Hiramatsu K; Moriya S; Takahashi K; Kawakita M
    Br J Cancer; 2015 Nov; 113(10):1493-501. PubMed ID: 26505680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study.
    Ma X; Guo W; Yang S; Zhu X; Xiang J; Li H
    Dis Markers; 2015; 2015():814670. PubMed ID: 26265795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating serum exosomes i-tRF-AspGTC and tRF-1-SerCGA as diagnostic indicators for non-small cell lung cancer.
    Peng J; Zhang Y; Zhou G; Shao L; Li L; Zhang Z
    Clin Transl Oncol; 2024 Aug; 26(8):1988-1997. PubMed ID: 38502292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum biomarker profiles as diagnostic tools in lung cancer.
    Nolen BM; Langmead CJ; Choi S; Lomakin A; Marrangoni A; Bigbee WL; Weissfeld JL; Wilson DO; Dacic S; Siegfried JM; Lokshin AE
    Cancer Biomark; 2011-2012; 10(1):3-12. PubMed ID: 22297547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin predicts all-cause mortality in male but not female end-stage renal disease patients on hemodialysis.
    Li X; Liu Y; Hocher JG; Chu C; Reichetzeder C; Kalk P; Szakallova A; Chen X; Krämer BK; Tepel M; Hocher B
    Cardiorenal Med; 2024 Jul; ():. PubMed ID: 39004070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantification of serum monounsaturated and polyunsaturated phosphatidylcholines as potential biomarkers for diagnosing non-small cell lung cancer.
    Chen Y; Ma Z; Zhong J; Li L; Min L; Xu L; Li H; Zhang J; Wu W; Dai L
    Sci Rep; 2018 May; 8(1):7137. PubMed ID: 29740076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on the relationship between serum periostin, MMP-7, TGF-β, and IL-18 levels and the clinical course and prognosis of COVID-19.
    Tuna ME; Kerget B; Aksakal A; Eğilmez E; Araz Ö; Uçar EY; Sağlam L
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2960-2968. PubMed ID: 38639532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis.
    Li F; Wang P; Ye J; Xie G; Yang J; Liu W
    Front Oncol; 2024; 14():1303918. PubMed ID: 38476362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current evidence regarding the cellular mechanisms associated with cancer progression due to cardiovascular diseases.
    Attachaipanich T; Chattipakorn SC; Chattipakorn N
    J Transl Med; 2024 Jan; 22(1):105. PubMed ID: 38279150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer.
    Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S
    J Mol Med (Berl); 2023 Dec; 101(12):1603-1614. PubMed ID: 37831111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum periostin levels and the severity of arsenic-induced skin lesions.
    Khatun M; Siddique AE; Wahed AS; Haque N; Tony SR; Islam J; Alam S; Sarker MK; Kabir I; Hossain S; Sumi D; Saud ZA; Barchowsky A; Himeno S; Hossain K
    PLoS One; 2023; 18(1):e0279893. PubMed ID: 36598904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periostin: biology and function in cancer.
    Dorafshan S; Razmi M; Safaei S; Gentilin E; Madjd Z; Ghods R
    Cancer Cell Int; 2022 Oct; 22(1):315. PubMed ID: 36224629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors.
    Wasik A; Ratajczak-Wielgomas K; Badzinski A; Dziegiel P; Podhorska-Okolow M
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis.
    Li M; Ma G; Li X; Zhou Q
    Med Sci Monit; 2022 Jul; 28():e936898. PubMed ID: 35891604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of periostin in lung cancer-related malignant pleural effusion.
    Zhang J; Zha T; Zhang N; Sun G
    J Clin Lab Anal; 2022 Feb; 36(2):e24179. PubMed ID: 35152510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of the ovarian cancer secretome: a systematic investigation.
    Kamble PR; Breed AA; Pawar A; Kasle G; Pathak BR
    Arch Gynecol Obstet; 2022 Sep; 306(3):639-662. PubMed ID: 35083554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.